The immunogenic part of infliximab is the F(ab′)2, but measuring antibodies to the intact infliximab...
The immunogenic part of infliximab is the F(ab′)2, but measuring antibodies to the intact infliximab molecule is more clinically useful
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd and British Society of Gastroenterology
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd and British Society of Gastroenterology
Subjects
More information
Scope and Contents
Contents
ObjectivesTo localise the immunogenic part of infliximab and evaluate the clinical usefulness of measuring antibodies against infliximab fragments.DesignObservational study.SettingsA specialised inflammatory bowel disease (IBD) centre in a tertiary hospital.InterventionsSerum was collected from patients with IBD and controls. Antibodies against who...
Alternative Titles
Full title
The immunogenic part of infliximab is the F(ab′)2, but measuring antibodies to the intact infliximab molecule is more clinically useful
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_874179011
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_874179011
Other Identifiers
ISSN
0017-5749
E-ISSN
1468-3288
DOI
10.1136/gut.2009.201533
